Skip to main content

Samir R. Patel, M.D.

Equibles does not estimate personal net worth.

Get an email with a short summary when Akari Therapeutics Plc publishes a filing, an earnings call transcript or a press release.

Get AKTX alerts

About Samir R. Patel, M.D.

Samir R. Patel, M.D. is recorded as CEO at Akari Therapeutics Plc (AKTX) since December 16, 2024. Akari Therapeutics Plc reported in an 8-K filed December 18, 2024 that Samir R. Patel, M.D. was appointed Chief Executive Officer and principal executive officer, effective December 16, 2024. Akari Therapeutics Plc reported in an 8-K filed June 5, 2024 that Samir R. Patel, M.D. was appointed Interim President and Chief Executive Officer, effective May 1, 2024. Akari Therapeutics Plc reported in an 8-K filed May 1, 2024 that Samir R. Patel, M.D. was appointed Interim President and Chief Executive Officer, effective May 1, 2024. Akari Therapeutics Plc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Akari Therapeutics Plc includes Abizer Gaslightwala (CEO and Board Member), Samir R. Patel (CEO), Hoyoung Huh (Chairman and Board Member) and 6 others.

“On December 12, 2024, the board of directors (the "Board") Akari Therapeutics, Plc (the "Company") approved the appointment of Samir R. Patel, M.D. to Chief Executive Officer and principal executive officer, effective December 16, 2024.”
Akari Therapeutics Plc Form 8-K, filed December 18, 2024 · Read the filing
“on April 25, 2024, the board of directors (the “Board”) of Akari Therapeutics, Plc (the “Company”) appointed Samir R. Patel, M.D., a member of the Board, as Interim President and Chief Executive Officer, effective May 1, 2024, to serve in such capacities until such time as determined by the Board.”
Akari Therapeutics Plc Form 8-K, filed June 5, 2024 · Read the filing

Affiliation history

Company network

Leadership on record at Akari Therapeutics Plc

Recent activity